Liraglutide is effective in treating type 2 diabetes in adults; side effects include nausea and vomiting, bloating and diarrhea. Liraglutide Injection is mainly used for blood glucose control in adults with type 2 diabetes mellitus, and is indicated for patients with poor hypoglycemic effect after treatment with the maximum tolerable dose of metformin or sulfonylurea alone, and in combination with metformin or sulfonylurea; it is indicated for the reduction of the risk of prevalence of major cardiovascular diseases in adult patients with type 2 diabetes mellitus accompanied by cardiovascular diseases. Side effects of this drug include: nausea and vomiting, bloating and diarrhea, dyspepsia, hypoglycemia, anorexia, dizziness, constipation, dehydration, bronchitis, nasopharyngitis, headache, and toothache. It is prohibited for those who are allergic to the active ingredients or other excipients of this product, and it is prohibited for pregnant and lactating women. Liraglutide injection does not treat patients with type 1 diabetes mellitus, patients with diabetic ketoacidosis, patients with congestive heart failure, patients with inflammatory bowel disease and diabetic gastroparesis. It is not indicated for patients with a history or family history of medullary thyroid carcinoma or patients with type 2 multiple endocrine tumors. If you need to use liraglutide injection please consult a professional doctor, under the guidance of the doctor reasonable injection of drugs.